CN Patent

CN101304656B — 4-((苯氧基烷基)硫代)-苯氧基乙酸衍生物的新型赖氨酸盐

Assigned to Janssen Pharmaceutica NV · Expires 2013-03-13 · 13y expired

What this patent protects

本发明涉及新颖的赖氨酸盐、含有它们的药物组合物以及它们在治疗由PPARδ介导的疾病和病症中的应用。本发明进一步涉及新颖的所述赖氨酸盐的制备方法。

USPTO Abstract

本发明涉及新颖的赖氨酸盐、含有它们的药物组合物以及它们在治疗由PPARδ介导的疾病和病症中的应用。本发明进一步涉及新颖的所述赖氨酸盐的制备方法。

Drugs covered by this patent

seladelpar-lysine (SELADELPAR LYSINE)

Patent Metadata

Patent number: CN101304656B
Jurisdiction: CN
Classification: —
Expires: 2013-03-13
Drug substance claim: No
Drug product claim: No
Assignee: Janssen Pharmaceutica NV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.